Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delavie Sciences is a biotechnology company specializing in the development of advanced skincare and longevity products derived from extremophile organisms. Co-founded by Dr. David Sinclair, a leading expert in aging research, the company utilizes proprietary biological extracts to address skin health at the cellular level. Their core technology involves Bacillus Lysate, an ingredient developed in collaboration with NASA that demonstrates significant UV protection and DNA repair capabilities. Delavie's product portfolio, marketed under the Aeonia brand, focuses on anti-aging, hydration, and environmental protection. The company aims to translate complex longevity science into accessible consumer health solutions through clinically validated topical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delavie Sciences.